Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details) - Part-5

v3.24.1
Stockholders' Equity (Details) - Part-5 - USD ($)
 1 Months Ended 12 Months Ended
Sep. 04, 2023
May 19, 2022
Apr. 29, 2021
Dec. 31, 2023
Dec. 31, 2022
Aug. 31, 2023
Apr. 30, 2023
Stockholders' Equity [Line Items]              
Issued an aggregate (in Shares)   710   11,889 739    
Aggregate issuance date fair value (in Dollars)       $ 89,189 $ 331,591    
Restricted shares (in Shares)         32    
Bid price per share         $ 1,539    
Amortization of the Restricted Stock Shares (in Dollars)     $ 50,000 $ 17,820 $ 26,325    
Exercise of warrants issued (in Shares)       534,719 197,209    
Shares issued (in Shares) 6,312     14 135,339 477,058 82,668
Purchase of aggregate common stock (in Shares)   298          
Exercise price per share   $ 516.8          
Aggregate issuance date fair value (in Dollars) $ 62,440 $ 115,936          
Share grant to issue (in Shares)   352          
Shares granted Grant value   $ 130,000          
Grant date value   261,704          
Grant date fair value $ 22,928            
Stock-based compensation expense (in Dollars)       $ 2,176,314 $ 2,607,501    
Unrecognized stock-based compensation expense (in Dollars)       $ 491,363      
Weighted average remaining vesting period       1 year 18 days      
Restricted Stock [Member]              
Stockholders' Equity [Line Items]              
Aggregate issuance date fair value (in Dollars)         $ 48,600    
Common Stock [Member]              
Stockholders' Equity [Line Items]              
Bid price per share       $ 1      
Shares issued (in Shares)       734,262      
Exercise price per share $ 12.73            
Common stock exercise price (in Shares) 5,525            
Aggregate fair value (in Dollars) $ 54,635            
Common stock exercise price (in Shares) 2,356            
Director [Member]              
Stockholders' Equity [Line Items]              
Exercise price per share   $ 516.8          
Granted options for purchase of shares (in Shares)   352          
Consultant [Member]              
Stockholders' Equity [Line Items]              
Granted options for purchase of shares (in Shares)   710          
Warrants to Purchase Common Stock [Member]              
Stockholders' Equity [Line Items]              
Exercise of warrants issued (in Shares)          
Black Scholes Option Model [Member]              
Stockholders' Equity [Line Items]              
Exercise price per share $ 12.73            
Amendment to the August 2023 Offering [Member] | Common Stock [Member]              
Stockholders' Equity [Line Items]              
Exercise of warrants issued (in Shares)       734,262      
Common stock at an exercise price per share $ 12.73